bpc-157 clinical trial australia 10mg – Perth BioTech BPC-157 + TB-500 Research Blend
Description
(Czechia) Validated assay content 10.71 mg Purity greater than 99.8 percent Retention time and spectral identity confirmation Endotoxin level 0.0120 EU per mg No detectable microbial contamination No detectable heavy metals For research use only not for human or veterinary use For laboratory research only
Additional ongoing research of BPC 157 in humans could not be identified
doi: 10.1007/s00792-009-0233-7
[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Bharadwaj V., Tzabazis A., Klukinov M., Manering N., Yeomans D
[PubMed] [Google Scholar][15] Seitz R
